SE466787B - Anvaendning av l-karnosin som immunoregulator foer behandling av immunsjukdomar - Google Patents

Anvaendning av l-karnosin som immunoregulator foer behandling av immunsjukdomar

Info

Publication number
SE466787B
SE466787B SE8505121A SE8505121A SE466787B SE 466787 B SE466787 B SE 466787B SE 8505121 A SE8505121 A SE 8505121A SE 8505121 A SE8505121 A SE 8505121A SE 466787 B SE466787 B SE 466787B
Authority
SE
Sweden
Prior art keywords
carnosine
disease
mice
reaction
immune diseases
Prior art date
Application number
SE8505121A
Other languages
English (en)
Swedish (sv)
Other versions
SE8505121D0 (sv
SE8505121L (sv
Inventor
K Nagai
T Suda
Original Assignee
Univ Nihon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Nihon filed Critical Univ Nihon
Publication of SE8505121D0 publication Critical patent/SE8505121D0/xx
Publication of SE8505121L publication Critical patent/SE8505121L/xx
Publication of SE466787B publication Critical patent/SE466787B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
SE8505121A 1985-02-13 1985-10-30 Anvaendning av l-karnosin som immunoregulator foer behandling av immunsjukdomar SE466787B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60025494A JPS61186322A (ja) 1985-02-13 1985-02-13 免疾調節剤

Publications (3)

Publication Number Publication Date
SE8505121D0 SE8505121D0 (sv) 1985-10-30
SE8505121L SE8505121L (sv) 1986-08-14
SE466787B true SE466787B (sv) 1992-04-06

Family

ID=12167607

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8505121A SE466787B (sv) 1985-02-13 1985-10-30 Anvaendning av l-karnosin som immunoregulator foer behandling av immunsjukdomar

Country Status (9)

Country Link
US (1) US4717716A (fr)
JP (1) JPS61186322A (fr)
CH (1) CH666188A5 (fr)
DE (1) DE3540632A1 (fr)
DK (1) DK171288B1 (fr)
FR (1) FR2577138B1 (fr)
GB (1) GB2170707B (fr)
NL (1) NL8600112A (fr)
SE (1) SE466787B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6314728A (ja) * 1986-07-03 1988-01-21 Zeria Shinyaku Kogyo Kk 肝障害の予防、治療剤
US4942530A (en) * 1987-03-02 1990-07-17 Mazda Motor Corporation Control of vehicle automatic transmission
US5110600A (en) * 1988-01-25 1992-05-05 The Regents Of The University Of California Method of treating viral infections with amino acid analogs
JPH0235057A (ja) * 1988-04-26 1990-02-05 Kinuko Nagai 機能性食品
JPH0717505B2 (ja) * 1989-02-23 1995-03-01 絹子 永井 骨粗鬆症予防剤
EP0593585B1 (fr) * 1991-07-05 2002-05-02 Peptech Limited Peptide neutralisant la toxicite du facteur de necrose tumorale alpha (fnt) et la toxicite des lipopolysaccharides (lps)
WO1993002706A1 (fr) * 1991-07-26 1993-02-18 Commonwealth Scientific And Industrial Research Organisation Systeme d'administration de vaccin peptidique produisant son propre adjuvant et production du vaccin
AU660047B2 (en) * 1991-09-09 1995-06-08 King's College London Method for the treatment of the complications and pathology of diabetes
US5561110A (en) * 1991-09-09 1996-10-01 Peptide Technology Limited Method for the treatment of the complications and pathology of diabetes
DE4307983A1 (de) * 1993-03-13 1994-09-15 Beiersdorf Ag Wirkstoffe und kosmetische und dermatologische Zubereitungen
RU2056852C1 (ru) * 1994-03-18 1996-03-27 Иван Николаевич Головистиков Средство для лечения аутоиммунных заболеваний с иммунодефицитом супрессоров и способ лечения аутоиммунных заболеваний
RU2058553C1 (ru) * 1994-03-18 1996-04-20 Иван Николаевич Головистиков Способ определения супрессорного звена иммунного статуса человека
US5576287A (en) * 1994-04-29 1996-11-19 Wake Forest University Method for treating acute renal disease and failure
KR960010020A (ko) 1994-09-09 1996-04-20 도리이 신이치로 조혈 기능 항진제
JPH0881371A (ja) * 1994-09-09 1996-03-26 Suntory Ltd 造血機能亢進剤
JP3877807B2 (ja) * 1996-07-03 2007-02-07 ゼリア新薬工業株式会社 口内炎治療・予防剤
JPH1029939A (ja) * 1996-07-17 1998-02-03 Zeria Pharmaceut Co Ltd 創傷治癒促進剤
AU2008306192A1 (en) * 2007-09-11 2009-04-09 Mondobiotech Laboratories Ag Use of leptin (22-56 ) as a therapeutic agent
IT1391251B1 (it) * 2008-10-15 2011-12-01 Innovative Nutrition & Pharma Srl Composizione per il trattamento delle patologie articolari
JP2012219080A (ja) * 2011-04-12 2012-11-12 Anbas:Kk 経口投与により腫瘍の発生又は増殖を抑止する組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4446149A (en) * 1981-12-14 1984-05-01 Kineshiro Nagai Medicine for treatment of cervical erosion
JPS6016934A (ja) * 1983-07-06 1985-01-28 Kaneshiro Nagai 抗腫瘍剤

Also Published As

Publication number Publication date
DK171288B1 (da) 1996-08-26
DE3540632A1 (de) 1986-08-21
FR2577138A1 (fr) 1986-08-14
GB2170707A (en) 1986-08-13
US4717716A (en) 1988-01-05
SE8505121D0 (sv) 1985-10-30
DK500585D0 (da) 1985-10-31
CH666188A5 (de) 1988-07-15
JPH0481966B2 (fr) 1992-12-25
DK500585A (da) 1986-08-14
JPS61186322A (ja) 1986-08-20
GB2170707B (en) 1989-02-15
GB8527243D0 (en) 1985-12-11
SE8505121L (sv) 1986-08-14
NL8600112A (nl) 1986-09-01
DE3540632C2 (fr) 1992-09-17
FR2577138B1 (fr) 1990-06-22

Similar Documents

Publication Publication Date Title
SE466787B (sv) Anvaendning av l-karnosin som immunoregulator foer behandling av immunsjukdomar
DEVLIN et al. Captopril in human blood and breast milk
JP2004531516A (ja) 新規ベンジリデンアミノグアニジンおよびそれらのメラノコルチンレセプターリガンドとしての使用方法
JPH0469129B2 (fr)
Ratner et al. Stimulatory effects of prostaglandin E1 on rat anterior pituitary cyclic AMP and luteinizing hormone release
JPH0662407B2 (ja) 安定化された３―オキシゲルミルプロピオン酸ポリマーを有効成分とする免疫調整剤
CA2631166A1 (fr) Sels et melanges d'acide 9-oxoacridine-10-acetique et de 1-alkylamino-1-desoxypolyols, compositions pharmaceutiques les contenant, et methodes de traitement associees
Tanaka et al. Effects of EM574 and cisapride on gastric contractile and emptying activity in normal and drug-induced gastroparesis in dogs
Cooper et al. Mechanism of action of vasopressin on prostaglandin synthesis and vascular function in the isolated rat kidney: effect of calcium antagonists and calmodulin inhibitors
US4914121A (en) 3-Phenyl-1-phenylpyrazole-4 acetic acid compounds which are useful in treating immune diseases
Ljungdahl-Ståhle et al. Penetration of zidovudine and 3'-fluoro-3'-deoxythymidine into the brain, muscle tissue, and veins in cynomolgus monkeys: relation to antiviral action
Nadler et al. Site of formation of thyroglobulin in mouse thyroid as shown by radioautography with leucine-H3.
JPH0641411B2 (ja) 免疫調節剤
CA1270762A (fr) Compositions pharmaceutiques renfermant un derive de l'acide maleopimarique
JPS61204120A (ja) 免疫調節剤
FR2485371A1 (fr) Nouvelle composition a usage therapeutique a base de lysine et d'arginine
JPH0542410B2 (fr)
JP3029902B2 (ja) 血清脂質増加剤
US3130189A (en) Hydroxocobalamin-glutathione
POLEC et al. Protective effect of ascorbic acid, isoascorbic acid and mannitol against tetracycline-induced nephrotoxicity
RU2276991C1 (ru) Тонизирующее и актопротекторное средство "серпистен"
Matsuzaki et al. Inhibition of cortical collecting tubule chloride transport by organic acids.
WO2023249512A1 (fr) Agent de traitement de maladie due aux radiations
Schlenker Some biochemical aspects of benzoyl para-aminosalicylic acid metabolism
SU1009427A1 (ru) Способ определени биологической активности пролактина в препаратах

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8505121-7

Format of ref document f/p: F

NUG Patent has lapsed